The largest database of trusted experimental protocols

7 protocols using tesr1

1

Generating Human RPE Cells from iPSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
The maintenance of human ARPE‐19 cells has been described (Dunn et al., 1996 (link)). Human induced Pluripotent stem cells (CB6.2 line) were maintained in TeSR1 (STEMCELL Technologies) for 10 days, and placed in differentiation medium for 50 days, and plated onto Matrigel‐coated plates in RPE medium as described (Maruotti et al., 2013 (link)). RPE cells were grown for 3 months and exposed to Cigarette Smoke Extract (CSE; Murty Pharmaceuticals) for 24 hr.
+ Open protocol
+ Expand
2

iPSC-derived Keratinocyte Differentiation

Check if the same lab product or an alternative is used in the 5 most similar protocols
iPSCs were maintained feeder-free on Geltrex-coated (ThermoFisher Scientific) tissue culture plastic in TesR1 (STEMCELL Technologies, Vancouver, BC, Canada). For keratinocyte differentiation, mid-passage iPSCs at ~50% confluency in six-well plates had media changed to defined keratinocyte-SFM media supplemented with 25 ng/ml BMP-4 (Bio-Techne, Minneapolis, MN, USA) and 1 μM RA (STEMCELL Technologies) for the first 96 h, at which point the BMP4 and RA were removed, followed by media changes every 72 h thereafter until epithelial cell morphology became apparent (~10 days). At this timepoint, the media was switched to Cnt-07 (CELLnTEC, Bern, Switzerland) and the cells cultured until confluency. At this point they were pre-treated with ROCK inhibitor (Y-27632, VWR) for at least 1 h and passaged using Accutase (STEMCELL Technologies) onto 10 cm2 tissue culture plates coated with collagen I/collagen IV, where rapid attachment-mediated enrichment of Krt14+ cells was performed as previously described. Resultant iPSC-keratinocyte cultures were cultured in Cnt-07 media containing 10 μM ROCK inhibitor until first media change after plating (CELLnTEC).
+ Open protocol
+ Expand
3

Optimized 3D Differentiation of Pluripotent Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
One hESC line (H9, WiCell) one neonatal iPSC line (Neo1, male 38, 39) and one adult iPSC line (AD3, from a 37‐year‐old female 40) were adapted from MEF‐supported to feeder‐free culture conditions on 6 well plates coated with growth factor‐reduced Matrigel basement membrane matrix (GFRM; Corning, New York) in TeSR1 (Stem Cell Technologies, Vancouver, Canada) defined medium. Cells were fed daily and passaged every 5 days at a ratio of up to 1:10 using 0.02% versene EDTA (Lonza, Basel, Switzerland). Cells were then differentiated by initiating EB formation, followed by long‐term culture (up to 150 days). EBs were generated either by mechanical, enzymatic, or dissociation–reaggregation approaches (Fig. 1). Each method was tested in the presence or absence of ROCK inhibitor (Y‐27632, Chemdea, NJ) for the first 48 hours of differentiation, during the early phase of EB formation. All cultures were tested in parallel under either stationary (static, “St”) or shaking (“Sh”) conditions throughout differentiation. Shaking cultures were achieved by placing cells on an orbital shaker (30 rpm, Stuart) housed inside the incubator for the entire period of differentiation, or in the case of EBs generated via the dissociation–reaggregation method, from day 12 onward. Biological replicates were performed in triplicate (n ≥ 3) for all experimental conditions tested.
+ Open protocol
+ Expand
4

Efficient iPSC Keratinocyte Differentiation

Check if the same lab product or an alternative is used in the 5 most similar protocols
iPSCs were maintained feeder-free on Geltrex-coated (ThermoFisher Scientific) tissue culture plastic in TesR1 (STEMCELL Technologies, Vancouver, BC, Canada). For keratinocyte differentiation, mid-passage iPSCs at ~ 50% confluency in six-well plates had media changed to defined keratinocyte-SFM media supplemented with 25 ng/ml BMP-4 (Bio-Techne, Minneapolis, MN, USA) and 1 μM RA (STEMCELL Technologies) for the first 96 h, at which point the BMP4 and RA were removed, followed by media changes every 72 h thereafter until epithelial cell morphology became apparent (~10 days). At this timepoint, the media was switched to Cnt-07 (CELLnTEC, Bern, Switzerland) and the cells cultured until confluency. At this point they were pre-treated with ROCK inhibitor (Y-27632, VWR) for at least 1 h and passaged using Accutase (STEMCELL Technologies) onto 10 cm2 tissue culture plates coated with collagen I/collagen IV, where rapid attachment-mediated enrichment of Krt14+ cells was performed as previously described. Resultant iPSC-keratinocyte cultures were cultured in Cnt-07 media containing 10 μM ROCK inhibitor until first media change after plating (CELLnTEC).
+ Open protocol
+ Expand
5

Generation of iPSC-derived MSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
iPSCs were maintained feeder-free on Geltrex-coated tissue culture plastic in TesR1 (STEMCELL Technologies). Differentiation to MSCs was initiated by transferring mid-passage iPSCs at 50% confluency to MSC medium, which consisted of Minimal Essential Medium Alpha supplemented with 5% fetal bovine serum, 5% horse serum and 10 ng/ml each of human PDGF-AB, EGF, and bFGF (all from PeproTech, Rocky Hill, NJ, USA). Media was changed every 48 h until cells with fibroblastic morphology were apparent and cultures neared confluency. At this point, MSC cultures were pre-treated with 10 μM ROCK inhibitor for at least 1 h and dissociated using a 50:50 mixture of Accutase and 0.25% Trypsin-EDTA incubated at 37 ° C. When cells had detached, the Accutase/trypsin mixture was diluted with 2× volume of PBS +1% FBS +3 mM EDTA to prevent clumping. Cells were centrifuged at 400g for 5 min and re-plated onto gelatin-coated plates in growth media plus cytokines containing 5 μM ROCK inhibitor to enhance plating efficiency. Between passages 3–5, cultures can be weaned off of ROCK inhibitor during passage. Flow cytometry analysis was performed using the following antibodies, all from eBioscience (San Diego, CA, USA): Anti-Human CD73 eFluor 450, 48-0739; anti-Human CD105 (Endoglin) PE, 12-1057; and anti-Human CD90 (Thy-1) APC, 17-0909.
+ Open protocol
+ Expand
6

Feeder-free iPSC to MSC Differentiation

Check if the same lab product or an alternative is used in the 5 most similar protocols
iPSCs were maintained feeder-free on Geltrex-coated tissue culture plastic in TesR1 (STEMCELL Technologies). Differentiation to MSCs was initiated by transferring mid-passage iPSCs at 50% confluency to MSC medium, which consisted of Minimal Essential Medium Alpha supplemented with 5% fetal bovine serum, 5% horse serum and 10 ng/ml each of human PDGF-AB, EGF, and bFGF (all from PeproTech, Rocky Hill, NJ, USA). Media was changed every 48 h until cells with fibroblastic morphology were apparent and cultures neared confluency. At this point, MSC cultures were pre-treated with 10 μM ROCK inhibitor for at least 1 h and dissociated using a 50:50 mixture of Accutase and 0.25% Trypsin-EDTA incubated at 37 ° C. When cells had detached, the Accutase/trypsin mixture was diluted with 2 × volume of PBS +1% FBS +3 mM EDTA to prevent clumping. Cells were centrifuged at 400g for 5 min and re-plated onto gelatin-coated plates in growth media plus cytokines containing 5 μM ROCK inhibitor to enhance plating efficiency. Between passages 3–5, cultures can be weaned off of ROCK inhibitor during passage. Flow cytometry analysis was performed using the following antibodies, all from eBioscience (San Diego, CA, USA): Anti-Human CD73 eFluor 450, 48-0739; anti-Human CD105 (Endoglin) PE, 12-1057; and anti-Human CD90 (Thy-1) APC, 17-0909.
+ Open protocol
+ Expand
7

Reprogramming of IEM PBMCs to iPSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood samples from non-IEM donors were obtained from the National Health Service Blood and Transplant (NHSBT) UK. Samples from IEM clinical trial subjects were obtained with their informed consent.
Peripheral Blood Mononuclear Cells (PBMC) were purified using the standard Ficoll-Paque procedure. Cells were expanded into erythroid progenitor cells and transduced with Sendai virus expressing Yamanaka factors OKSM (Life Technologies, Carlsbad, California). IPSC colonies were further expanded to virus-free clonal lines that were cultured and maintained on Matrigel (BD, Oxford, UK) in TeSR1 (STEMCELL Technologies, Vancouver, Canada) and passaged every 6-7 days using Dispase (Life Technologies, Carlsbad, California ).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!